Single cell resolution analysis of multi-tissue derived human iNKT cells reveals novel transcriptional paradigms
Jayasinghe, R. G.; Hollingsworth, D.; Boonchalermvichian, C.; Gupta, B.; Yan, H.; Baker, J.; Dejene, B.; Weinberg, K. I.; Negrin, R. S.; Mavers, M.
Show abstract
Invariant natural killer T (iNKT) cells are evolutionarily conserved innate lymphocytes important for host defense against pathogens. Further, they are increasingly recognized to play a role in tumor immune surveillance and in protection against graft versus host disease, and they are of particular importance as a universal donor for cellular therapies. Therefore, a thorough understanding of the biology of iNKT cells is critical. Murine studies have revealed the existence of transcriptionally and functionally distinct subsets, similar to T helper cell subsets. However, a comprehensive study of human iNKT cell heterogeneity is lacking. Herein, we define the transcriptomic heterogeneity of human iNKT cells derived from multiple immunologically relevant tissues, including peripheral blood, cord blood, bone marrow, and thymus, using single cell RNA-sequencing. We describe human iNKT cells with a naive/precursor transcriptional pattern, a Th2-like signature, and Th1/17/NK-like gene expression. This combined Th1/17 pattern of gene expression differs from previously described murine iNKT subsets in which Th1- and Th17- like iNKT cells are distinct populations. We also describe transcription factors regulating human iNKT cells with distinct gene expression patterns not previously described in mice. Further, we demonstrate a novel T effector memory RA+ (TEMRA)-like pattern of expression in some human iNKT cells. Additionally, we provide an in-depth transcriptional analysis of human CD8+ iNKT cells, revealing cells with two distinct expression patterns--one consistent with naive/precursor cells and one consistent with Th1/17/NK-like cells. Collectively, our data provide critical insights into the transcriptional heterogeneity of human iNKT cells, providing a platform to facilitate future functional studies and to inform the development of iNKT-based cellular therapies.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Augmented expansion of Treg cells from healthy and autoimmune subjects via adult progenitor cell co-culture. 96%
- A single-cell atlas of lymphocyte adaptive immune repertoires and transcriptomes reveals age-related differences in convalescent COVID-19 patients 96%
- Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways 95%
Similar papers in this journal
Similar papers in this journal
- Longitudinal analysis of invariant natural killer T cell activation reveals a cMAF-associated transcriptional state of NKT10 cells 97%
- The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency 96%
- Lymphoid origin of a lineage of intrinsically activated plasmacytoid dendritic cell in mice and humans 96%
Similar papers in this journal
- Transcriptome and Chromatin Landscape of iNKT cells are Shaped by Subset Differentiation and Antigen Exposure 96%
- Engineered niches support the development of human dendritic cells in humanized mice 96%
- Expression of terminal deoxynucleotidyl transferase (TdT) identifies lymphoid-primed progenitors in human bone marrow 95%
Similar papers in this journal
- Meta-analysis reveals consistent immune response patterns in COVID-19 infected patients at single-cell resolution 95%
- Complex genotype-phenotype relationships shape the response to treatment of Down Syndrome Childhood Acute Lymphoblastic Leukaemia 94%
- Single-Cell Mass Cytometry on Peripheral Blood Identifies Immune Cell Subsets Associated with Primary Biliary Cholangitis 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.